{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:53:30Z","timestamp":1782316410469,"version":"3.54.5"},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:p>This cohort study examines patterns of bone-modifying agent use from 2013 to 2024 among men with metastatic castration-resistant prostate cancer.<\/jats:p>","DOI":"10.1001\/jamanetworkopen.2026.20084","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:31:45Z","timestamp":1782315105000},"page":"e2620084","source":"Crossref","is-referenced-by-count":0,"title":["Bone-Modifying Agents in Metastatic Castration-Resistant Prostate Cancer"],"prefix":"10.1001","volume":"9","author":[{"given":"Zeynep Irem","family":"Ozay","sequence":"first","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonjung","family":"Jo","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Gebrael","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah","family":"Ostrowski","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Mathew Thomas","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Li","sequence":"additional","affiliation":[{"name":"University of Kansas Cancer Center, Westwood"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryon P.","family":"Graf","sequence":"additional","affiliation":[{"name":"Foundation Medicine Inc, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumyajit","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L.","family":"Maughan","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avirup","family":"Guha","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Medical College of Georgia at Augusta University, Augusta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irbaz Bin","family":"Riaz","sequence":"additional","affiliation":[{"name":"Mayo Clinic in Arizona, Phoenix"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel S.","family":"Antonarakis","sequence":"additional","affiliation":[{"name":"Masonic Cancer Center, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana R.","family":"McKay","sequence":"additional","affiliation":[{"name":"University of California, San Diego, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umang","family":"Swami","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"issue":"9","key":"zld260108r1","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/cncr.30505","article-title":"Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancer.","volume":"123","author":"Klaassen","year":"2017","journal-title":"Cancer"},{"key":"zld260108r2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.canep.2019.05.013","article-title":"Incidence of skeletal-related events in patients with breast or prostate cancer-induced bone metastasis or multiple myeloma: a 12-year longitudinal nationwide healthcare database study.","volume":"61","author":"Baek","year":"2019","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"zld260108r3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMoa041943","article-title":"Risk of fracture after androgen deprivation for prostate cancer.","volume":"352","author":"Shahinian","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"zld260108r4","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/jnci\/djh141","article-title":"Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.","volume":"96","author":"Saad","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"zld260108r5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41391-022-00573-y","article-title":"Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer.","volume":"26","author":"Mitchell","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"zld260108r6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1200\/OP.23.00258","article-title":"Determinants of bone-modifying agent prescribing for metastatic castration-resistant prostate cancer in a national health care delivery system.","volume":"20","author":"Nguyen","year":"2024","journal-title":"JCO Oncol Pract"},{"issue":"3","key":"zld260108r8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S1470-2045(18)30860-X","article-title":"Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.","volume":"20","author":"Smith","year":"2019","journal-title":"Lancet Oncol"},{"issue":"3","key":"zld260108r9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.eururo.2024.11.027","article-title":"Decrease in fracture rate with mandatory bone-protecting agents in the EORTC 1333\/PEACE-3 Trial comparing radium-223 combined with enzalutamide versus enzalutamide alone: a safety analysis.","volume":"87","author":"Gillessen","year":"2025","journal-title":"Eur Urol"},{"issue":"15","key":"zld260108r10","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1200\/JCO.19.03148","article-title":"Bone health and bone-targeted therapies for prostate cancer: ASCO Endorsement of a Cancer Care Ontario Guideline.","volume":"38","author":"Saylor","year":"2020","journal-title":"J Clin Oncol"},{"key":"zld260108r7","doi-asserted-by":"crossref","unstructured":"Ma? X, Long? L, Moon? S, Adamson? BJS, Baxi? SS. Comparison of population characteristics in real-world clinical oncology databases in the US: Flatiron Health, SEER, and NPCR.? medRxiv. Preprint posted online June 7, 2023. doi:10.1101\/2020.03.16.20037143","DOI":"10.1101\/2020.03.16.20037143"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2850685\/ozay_2026_ld_260108_1781620498.05341.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:31:52Z","timestamp":1782315112000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2850685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.20084","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]}}}